Eli Lilly's stock surges despite recent decline, driven by innovative medicines and strong technical indicators, positioning it as an attractive investment for the future.
Eli Lilly's stock surges despite recent decline, driven by innovative medicines and strong technical indicators, positioning it as an attractive investment for the future.